Skip to Content

Logo 734 (Methylphenidate Hydrochloride Extended-Release 27 mg)

Pill with imprint Logo 734 is Gray, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 27 mg. It is supplied by Actavis Pharma, Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 27 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo 734

Methylphenidate hydrochloride extended-release 27 mg Logo 734

Methylphenidate Hydrochloride Extended-Release

Imprint
Logo 734
Strength
27 mg
Color
Gray
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
62037-0734

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.